chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numb face approximately 30 minutes after shots 1 and 2.; Hives on right arm after shot 1; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0167, expiration date was not reported), via an unspecified route of administration, administered in left arm on 30Apr2021 08:15 (at the age of 49-years-old) as dose 1, single for covid-19 immunization at public health clinic/veterans administration facility. The medical history included reynauds syndrome, hypothyroidism, high cholesterol. The patient historical vaccine included flu shot and experienced known allergies to flu shot. Concomitant medications included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (CRESTOR), vitamin d3, calcium, all taken for unknown indications from an unknown date. Other medications patient received in two weeks included synthroid, crestor, multi vitamin D3, calcium. Patient did not receive any other vaccines with in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 21May2021 17:00 the patient experienced numb face approximately 30 minutes after shots 1 and 2. Hives on right arm after shot 1. Went to urgent care next afternoon. The adverse events resulted in emergency room/department or urgent care. Prednisone for 7 days was received as treatment for the adverse events. Therapeutic measures were taken as a result of numb face approximately 30 minutes after shots 1 and 2, hives on right arm after shot 1. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
approx 16mos p/vax pt exp skin rash w/several lesions w/an erythematous base & raised blister-like lesions all over the body
Moderate swelling/ pinkness to upper half of upper left arm- itchy. Progressive over 48 hours after DTaP/IPV. Urticarial appearing. No significant bump at injection site.
fever; Chills; aches/soreness; ear pain; headache; sick stomach; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: Ew0162) via an unspecified route of administration in the left arm on 13Apr2021 at 11:30(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), melatonin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: En6204) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00am, the patient reported that after 12 hours symptoms started. On 14Apr2021 at 12:00am, the patient experienced chills, aches, soreness, ear pain, headache and sick stomach. On 14Apr2021 at 03:00, the patient experienced fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events fever, chills, aches, soreness, ear pain, headache and sick stomach was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
had tingling of lip and tongue but it was much less this time; felt some difficulty swallowing; This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient.  A female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 28Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: egg whites" (unspecified if ongoing), notes: Egg whites; "Food Allergy" (unspecified if ongoing), notes: Corn, Oats, Cinnamon; "Known allergies: Ragweed" (unspecified if ongoing), notes: Ragweed; "Known allergies: Safflower" (unspecified if ongoing), notes: Safflower; "severe allergies" (unspecified if ongoing), notes: Other medical history: Severe allergies; "Known allergies: all NSAIDS" (unspecified if ongoing), notes: all NSAIDS. Concomitant medication(s) included: FLONASE [FLUTICASONE PROPIONATE]; CLARITIN-D; MUCINEX; PREDNISONE; BENADRYL; PEPCID [FAMOTIDINE]. Past drug history included: Aspirin, reaction(s): "Known allergies: Aspirin". Vaccination history included: BNT162B2 (Dose 1, Single, (Lot # not provided)), for COVID-19 immunisation, reaction(s): "my bottom lip began to tingle and go numb, then the tip of the tongue did that, then that continued to half of my tongue", "my bottom lip began to tingle and go numb, then the tip of the tongue did that, then that continued to half of my tongue". The following information was reported: PARAESTHESIA ORAL (non-serious), outcome "recovered", described as "had tingling of lip and tongue but it was much less this time"; DYSPHAGIA (non-serious), outcome "recovered", described as "felt some difficulty swallowing". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of paraesthesia oral, dysphagia. Additional Information: On the first dose, the patient experienced her bottom lip began to tingle and went numb, then the tip of the tongue did that, then that continued to half of her tongue (immediately took Benadryl and Pepcid, once home added Prednisone). For the second dose, she took "cocktail" of Prednisone, Benadryl, and Pepcid before she went in to get vaccine. She also experienced, like 1st shot, tingling of lip and tongue but it was much less this time because she was proactive and also felt some difficulty swallowing but never lost ability to swallow, talk, or sing. The patient has not been diagnosed with COVID prior vaccination. The patient has been tested for COVID post vaccination through nasal swab with negative results.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021351467 Same patient, same drug with different vaccine dose, different AE.;US-PFIZER INC-2021351467 Same patient and drug; Different dose and event
This spontaneous report as received from a nurse refers to a 18 month old male patient. On 210-MAY-2014 the patient was vaccinated with VARIVAX (lot# and expiration date not provided) (dose not reported). It was reported that the patient received improperly store VARIVAX exposed to maximum temperature of -7C for 27 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Body ache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body ache). At the time of the report, MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use were not provided by the reporter.  Treatment medication was not provided.   Reporter did not allow further contact
Large local lasting 3 days.  Generalized urticaria lasting 3 wks.  Required systemic steroids & antihist.
3 1/2 hrs p/vax pt began screaming & screamed for >3hrs; entire thigh red & swollen from inject site to knee; had APAP a/vax-called MD & told to inc APAP, exercise leg & use warm bath;
A physician reported the occurrence of injection site cellulitis in a a 5-year-old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). The reporter submitted a report directly to VAERS (VAERS ID, 185347). The pt's medical history, concurrent conditions and concurrent medications were not provided. The pt had no adverse experiences following receipt of prior immunizations. On an unspecified date, the pt received an injection of Infanrix. On 04/25/2002 post-immunization the pt developed cellulitis at the injection site. The physician prescribed an unspecified antibiotic. The event was reported to have resolved as of 04/29/2002. The reporter considered the event to be possibly related to Infanrix immunization.
Moderna COVID-19 Vaccine EUA Injection site has pain and redness area is 8cm*5cm; touch the skin can feel the swelling; Other Side effects: have headache and whole body muscle pain, feel chills but sweating lots; slept almost 23 hours because of the dizziness.
Patient was at work and felt nauseous at around 0800 and took a Zofran. Then around 1030 she started to have lower chest (near the lower ribs) pain 9/10 pain and she was diaphoretic. We called 911 as we were concerned about an MI. She was transported via EMS to the hospital. They ran various tests and determined it wasn't cardiac or lung issues and was likely side effects from the COVID vaccine. On 1/8/21, Patient reports that she feels dizzy and is "itching all over." She took antihistamine and that helped the itching symptom.
Hot, red, itchy rash across the neck. The rash grew and spread and formed bumps. I applied hydrocortisone cream and took Benadryl but the rash has persisted.
Patient was taken to local hospital and admitted due to exacerbation of MS. He denies any infection issues and relays that all diagnostic studies have returned negative. He is currently on the Transitional Care Unit and states that the plan is for him to be discharged to home within the next several days.
Had side effects both times; Initial information regarding this unsolicited valid non-serious case was received from a consumer (patient) via a public post on the social media flu shot campaign on 12-Nov-2020.   This case involved an unknown demographic patient who reported that he had side effects both times (adverse event), while receiving INFLUENZA VACCINE.  Medical history, medical treatment, vaccination and family history of the patient were not provided.   Concomitant medication was not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date (unknown latency period), the patient reported he got the flu shot twice, two years in a row. He had side effects both times (adverse event), while received vaccine INFLUENZA VACCINE.   No relevant laboratory test was reported.  It was not reported if the patient received a corrective treatment.  The outcome was reported as unknown.
Lyme disease; pain and soreness at touch around injection site (left arm).; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on 26Feb2021 (Batch/Lot number was not reported) at arm left as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient reported pain and soreness at touch around injection site (left arm). The patient wants to know in which arm should she get the second dose. She was also diagnosed with possible Lyme disease. She has been prescribed a strong antibiotic to take for 3 week BID and probiotics. She is scheduled for the second on 19Mar2021. Therapeutic measures were taken as a result of lyme disease. The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Several of my friends got shingles from the shot/Suspected Vaccination failure; Several of my friends got shingles from the shot; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with vitamin e and lysine. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The patients were reporter's friend. The age at vaccination was not applicable to this report. The reporter stated that several of his/her friends (patients) got shingles from the shot and Lysine and Vitamin E stop and prevent it. The reporter stated that you did not need to shoot up poison unless you want to get sick. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
FEVER, CHILLS, NAUSEA, HEADACHE, AND LESIONS ON CHEST.  8 DAYS LATER, PATIENT REPORTS THAT  HE IS "STILL VERY ITCHY, WANTS TO DIG AND CLAW AT HIS SKIN, AND FEELS LIKE HE HAS THE WORST COLD/FLU OF HIS LIFE"  TODAY HE REPORTS SHORTNESS OF BREATH.  REFERRED  HIM TO HIS DR.
Rash, hives to face and arms, eventually started drooling, SOB, had to go to ER for treatment. She also had swelling a knot, and warmth to touch at injection site right arm. (Where Varivax was injected).
Right after I have a shooting pain right at the vaccination site. If I try to reach over my head or behind my back I get sharp pain. This has been going on for about 6 months. I will start physical therapy to get mobility back in my arm and ease the pain I get when I move my arm. I have discussed with my rheumatologist, hematologist, and made an appointment with my primary care doctor. I have not been prescribed any medications.
Narrative: COVID infection following COVID vaccine series 02/09, Pfizer, dose #1 03/02, Pfizer, dose #2 09/15 COVID swab, result: detected 09/16 pt cc: exposure: unknown
20AUG98 Injection site "red hot and swollen", ER called, hot compresses used,24AUG to MD,dx injection site infection,tx ATB, possible lancing
Pt is unable to move arm very well. He subsequently went to dr and physical therapy. A diagnosis has not yet been determined according to pt's wife, as of 11/18/10.
COVID+ 12/30/2022.  Vaccination Status - moderna x3   BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 12/30/2022 Discharge Date: 1/1/2023     Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 12/31/2022 Yes ? DKA, type 1, not at goal  12/30/2022 Unknown ? Hypertension 08/31/2022 Yes ? AKI (acute kidney injury) 05/25/2022 Yes ? Other emphysema 12/14/2020 Yes ? Hypothyroidism 11/18/2020 Unknown ? Type 1 diabetes mellitus with hyperglycemia   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: DKA, type 1, not at goal [E10.10] Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus [E10.10] COVID-19 [U07.1]   HOSPITAL COURSE:   Patient is a 67 y.o. female with a history of Type 1 diabetes, hypertension and COPD presented with a one day history of nausea, vomiting, fever, myalgia, generalized malaise, decreased appetite, intermittent cough and congestion. She denied any chest pain, abdominal pain or diarrhea. She took a home COVID test which was positive. This prompted her to the emergency department for evaluation.   Workup in the emergency department demonstrated an AKI and DKA. Her vitals were stable. Patient was started on Endotool and IV insulin. COVID-19 positive. She was admitted to critical care unit for further management of DKA with IV insulin, aggressive fluid resuscitation and EndoTool.   Patient's blood glucose levels were well controlled with IV insulin.  Her anion gap closed while on EndoTool.  Patient's bicarbonate level trended up.  AKI resolved.  Patient was able to transition to basal bolus insulin dosing.  Her blood glucose levels remained within range while on basal bolus insulin dosing.  Patient was able to tolerate advancement in her diet.  She was discharged home in stable condition
No adverse outcomes reported. Vaccine administered was passed the Beyond Use Date, as this date was misunderstood by clinic staff.
Extreme fatigue, chills, aches lasting 24 hrs. Also had a menstrual period a week later for the first time in 4 months.
Information has been received from a registered nurse concerning a 75 year old female with no medical history and no drug allergies who on 17-OCT-2006 at 2:00 PM was vaccinated with second dose of Pneumovax 23 (lot # 651400/0618F) (0.5 ml), intramuscularly in the right deltoid. Concomitant therapy included multi-vitamin supplements, low dose aspirin, alendronate sodium, folic acid, glucosamine and quinine. It was noted that the patient was "healthy at the time of vaccination." On 18-OCT-2006 "within 24 hours" the patient experienced redness, swelling and tenderness at the injection site. It was also reported that on 18-OCT-2006 the patient had chills, tenderness right biceps at injection site with left axillary and left anterior cervical adenopathy. It was also reported on 18-OCT-2006 that the patient had "increased arm swelling, red, tender around entire upper arm also axillary tenderness on same side." On 19-OCT-2006 the patient was examined in the office with redness, swelling and tenderness at the injection site involving the whole upper arm. The tenderness extended to the triceps and biceps of the injection area. Lymph node swelling in the neck and axilla area of the injection site was noted on 19-OCT-2006. The patient was given KEFLEX an antibiotic to prevent infection. It was also reported that the patient was treated with cephalosporin for possible cellulitis. The patient had received an earlier vaccination in October 1999 without any problems. The patient recovered on approximately 21-OCT-2006. It was noted that the patient did not have any adverse events following previous vaccinations. Additional information is not expected.
pt recvd vax 20MAY94 & 4-5 hrs later seemed lethargic, excessive x 1wk; no LOC; sleeping more than usual; & when awake is more fussy than usual; APAP given; 27MAY nl behavior returning; MD visit-nl exam; no other sx or tx;
Soon after 10 mins of vaccination, I started to feel burning in my stomach, after about 16 hours of vaccination, besides routine side effects, I started feeling  sore throat, runny nose and cough. These were  not listed  in the common side effects. I am unable to speak/ due to hoarse  and  my throat is scratchy.  Please also advise, if I may take the second dose or otherwise. Thanks
I was given the shot on Monday, I had many of the described symptoms, but, the Dr. found that my ears were bulging and I had some bronchial congestion. I was given a steroid shot in the left hip one week from the day I got the shingles shot. The next day I had some pain, the next day more in the same area, on the third day after the steroid shot I broke out in the night. I have shingles from my tailbone across my cheek and down my thigh to below my knee. I don't know, but it is possible that the steroid shot triggered this breakout. If this is a possibility, it would be good to warn medical personnel not to give a steroid shot soon after a shingles shot.
STORAGE IN REFRIGERATOR (2C-8C) UP TO 30 DAYS. (VACCINE USED AFTER 10/16/2021).
Child in office today for 12 mon shots plus flu vaccine. Fine during afternoon. With grandparents this evening. Became febrile. Developed stiffening, tonic clonic movement w/perioral cyanosis. Spell stopped within 1-2min. Driven by car to ER. Temp to 104. BP 67/23, pox 94% HR96. repeat vitals HR 170, BP79/40, pox 94-95%. Child upset w/exam  but consoles easily. Observed at ER. Discharged to home with office F/U and antipyretics.
Patiernt stated that the symptoms started on April 27th. He was first evaluated on the 30th of April. Upon exam palmar and interdigital surfaces noted small erythemic raised lesions with vesicular lesions noted on the left index finger and the right ring MP joint. Due the the presentation and recent vaccination he was taken to Hospital for further evaluation. The Dermatologist specializing in infectious disease believed the symptoms did not correlate with the small pox vaccine and placed him on Claricort twice a day for 7 days. The dermatologist would like to follow up with him in one week. The patients symptoms did not progress until today May 02, with small eruptions forming over elbows. The patient has denied any other symptoms at this time. The sites are slightly tender to palpation.
Bloody nose Left leg / foot pain Entire left side of body not correct Chest pain Shortness of breath Blurred vision Can't sleep
The patient had her vaccine on 6/10 and then on 6/11 began to experience tingling throughout her legs and feet.  She also complained of swelling in the feet in the mornings and shuffling gait.  She also noticed joint pain and cramping in the legs.  She still has these symptoms at this time.
Patient arrived to the ED on 12/11/2021 with complaints of chest tightness radiating to back that started on 12/11 Denied shortness of breath, but reported dizziness.  Low grade temp 100.1 12/14/2021  Did not require intubation or ICU admission  No supplemental oxygen was needed Patient requested monoclonal antibody treatment, patient was directed to receive outpatient upon discharge
9 days after getting the series I began to develop a Mobiliform erythmatous rash with intense itching. Started on my forearms and then spread up, trunk, back and legs. No relief with otc products.; 9 days after getting the series I began to develop a Mobiliform erythmatous rash with intense itching. Started on my forearms and then spread up, trunk, back and legs. No relief with otc products.; This is a spontaneous report received from a contactable physician (reporting on herself). A 36-years-old female patient received Second dose of BNT162B2 ((BNT162B2, Formulation: Solution for injection, Lot Number: El3249 and Expiration date was not reported) via an unspecified route of administration in Arm Left on 11Jan2021 17:00 as single dose for covid-19 immunisation. Medical history included hypothyroid, covid-19. Patient had no known allergies. Patient had covid prior vaccination. The historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number Eh9899 and Expiry date was not reported), via an unspecified route of administration in Arm Left on 21Dec2020 17:00 for COVID-19 immunization. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. Patient did not take any other vaccine in four weeks. It was re-ported that 9 days after getting the series she began to develop a Mobiliform erythmatous rash with intense itching. Started on her forearms and then spread up, trunk, back and legs. No relief with otc products. So far on steroid taper and still present coming back as taper is lessening. Itching was intense and rash is diffuse. The outcome of the events was not recovered.